Literature DB >> 6788140

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton.

W H Inman.   

Abstract

An independent, non-regulatory drug surveillance research unit has been established at the University of Southampton. Its first task will be to set up a prescription-event monitoring scheme in general practice to enable the pattern of adverse events, as distinct from suspected adverse reactions associated with new drugs to be compared with that of older medicines. Prescriptions for selected drugs will identify patients and a simple questionnaire, designed to be completed in under five minutes, will be used to obtain the required information. Medical opinions about causation need not be given, and the scheme will not interfere with normal prescribing practice.

Entities:  

Mesh:

Year:  1981        PMID: 6788140      PMCID: PMC1505289          DOI: 10.1136/bmj.282.6271.1216

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  Postmarketing studies: the work of the Drug Safety Research Unit.

Authors:  D J Finney
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 2.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

Review 3.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  A survey of adverse drug reactions in family practice.

Authors:  J L Reynolds
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

5.  Postmarketing surveillance of adverse drug reactions: problems and solutions.

Authors:  F M Lortie
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

Review 6.  Techniques of postmarketing surveillance. An overview.

Authors:  J L Carson; B L Strom
Journal:  Med Toxicol       Date:  1986 Jul-Aug

7.  Is the clinical trial evidence about new drugs statistically adequate?

Authors:  J M Bland; D R Jones; S Bennett; D G Cook; A P Haines; A J MacFarlane
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

Review 8.  Rare and serious adverse reactions.

Authors:  G R Venning
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

9.  The hope, hype and reality of Big Data for pharmacovigilance.

Authors:  Andrew Bate; Robert F Reynolds; Patrick Caubel
Journal:  Ther Adv Drug Saf       Date:  2017-10-31

10.  Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan.

Authors:  Kazuo Samizo; Eri Kawabe; Shiro Hinotsu; Tsugumichi Sato; Shigeru Kageyama; Chikuma Hamada; Yasuo Ohashi; Kiyoshi Kubota
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.